| DR REDDYS LABORATORIES Back to ShareHolding Pattern | 
Last 5 Year Total Public Shareholding ShareHolding (%) History of DR REDDYS LABORATORIES
Last 8 Quarters| Sep2025 | Jun2025 | Mar2025 | Dec2024 | Sep2024 | Jun2024 | Mar2024 | Dec2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| 62.53 % | 62.32 % | 61.82 % | 60.12 % | 59.14 % | 58.76 % | 58.00 % | 58.02 % | ||
What is the latest Total Public Shareholding Shareholding of DR REDDYS LABORATORIES ?
| Year | Total Public Shareholding | 
|---|---|
| Sep2025 | 62.53 % | 
| Jun2025 | 62.32 % | 
| Mar2025 | 61.82 % | 
| Dec2024 | 60.12 % | 
| Sep2024 | 59.14 % | 
| Jun2024 | 58.76 % | 
| Mar2024 | 58.00 % | 
| Dec2023 | 58.02 % | 
How is Total Public Shareholding Shareholding of DR REDDYS LABORATORIES Trending?
| Years | Total Public Shareholding | % Change | |
|---|---|---|---|
| Sep2025 | 62.53 % | 0.34 | |
| Jun2025 | 62.32 % | 0.81 | |
| Mar2025 | 61.82 % | 2.83 | |
| Dec2024 | 60.12 % | 1.66 | |
| Sep2024 | 59.14 % | 0.65 | |
| Jun2024 | 58.76 % | 1.31 | |
| Mar2024 | 58.00 % | -0.03 | |
| Dec2023 | 58.02 % | - | |
Compare Total Public Shareholding ShareHolding of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹99,964.2 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| MANKIND PHARMA | ₹98,333.5 Cr | -1.4% | -2.2% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| DR REDDYS LABORATORIES | -6.8% | -2.1% | -8.4% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    